Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Myoscience management update

    Myoscience Inc., Redwood City, Calif. Business: Dermatology Transitioned: Jeffrey Gold to CEO from president and COO

    Published on 11/10/2014
  • NeuroPhage management update

    NeuroPhage Pharmaceuticals Inc., Cambridge, Mass. Business: Neurology Hired: Franz Hefti as president and COO, formerly CSO of Avid Radiopharmaceuticals, which Eli Lilly and Co. acquired

    Published on 11/10/2014
  • Oragenics management update

    Oragenics Inc. (NYSE-M:OGEN), Alachua, Fla. Business: Dental, Infectious, Diagnostic Resigned: John Bonfiglio as president, CEO and a director; CFO Michael Sullivan becomes interim principal executive officer

    Published on 11/10/2014
  • Reckitt Benckiser management update

    Reckitt Benckiser Group plc (LSE:RB), Slough, U.K. Business: Neurology Hired: Cary Claiborne as CFO of Reckitt Benckiser's Reckitt Benckiser Pharmaceuticals Inc. subsidiary, formerly CFO of Sucampo Pharmaceuticals Inc.

    Published on 11/10/2014
  • ReGenX management update

    ReGenX Biosciences LLC, Washington, D.C. Business: Gene/Cell therapy Hired: Stephen Yoo as CMO, a newly created position, formerly medical science director of clinical development at AstraZeneca plc

    Published on 11/10/2014
  • Relypsa management update

    Relypsa Inc. (NASDAQ:RLYP), Redwood City, Calif. Business: Endocrine/Metabolic Hired: Scott Garland as SVP and chief commercial officer, formerly EVP and chief commercial officer of Exelixis Inc.

    Published on 11/10/2014
  • Salix management update

    Salix Pharmaceuticals Ltd. (NASDAQ:SLXP), Raleigh, N.C. Business: Autoimmune, Infectious, Gastrointestinal Resigned: Adam Derbyshire as EVP of finance and administration and CFO; Timothy Creech, SVP of finance and …

    Published on 11/10/2014
  • Theranostics Health management update

    Theranostics Health Inc., Rockville, Md. Business: Diagnostic, Supply/Service Hired: Luis Gutierrez as president, CEO and a director, formerly EVP and chief commercial officer of Aptiv Solutions, which ICON plc acquired…

    Published on 11/10/2014
  • Trino management update

    Trino Therapeutics Ltd., Dublin, Ireland Business: Inflammation, Gastrointestinal, Autoimmune Hired: Richard Davis as CEO, a newly created position, formerly healthcare investment manager at Wellcome Trust

    Published on 11/10/2014
  • Ubiquigent board of directors update

    Ubiquigent Ltd., Dundee, U.K. Business: Gene/Cell therapy, Supply/Service Appointed: Mark Treheme, a director, as chairman

    Published on 11/10/2014
  • Aileron management update

    Aileron Therapeutics Inc., Cambridge, Mass. Business: Inflammation, Cancer, Endocrine/Metabolic Hired: Manuel Aivado as CMO, formerly VP of clinical development and pharmacovigilance at Taiho Pharmaceutical Co. Ltd.'s …

    Published on 11/3/2014
  • Alere management update

    Alere Inc. (NYSE:ALR), Waltham, Mass. Business: Diagnostic Transitioned: Namal Nawana to president, CEO and a director from COO and interim president and CEO

    Published on 11/3/2014
  • BioNet-Asia management update

    BioNet-Asia Co. Ltd., Bangkok, Thailand Business: Infectious Hired: Georges Thiry as COO, effective early 2015, currently director of the Dengue Vaccine Initiative; he will succeed Dario Cresci

    Published on 11/3/2014
  • Cara management update

    Cara Therapeutics Inc. (NASDAQ:CARA), Shelton, Conn. Business: Neurology Deceased: CMO Robert Medve

    Published on 11/3/2014
  • Cardio3 BioSciences management update

    Cardio3 BioSciences S.A. (Euronext:CARD), Mont-Saint-Guibert, Belgium Business: Cardiovascular Hired: Warren Sherman as CMO, formerly a cardiologist at Columbia University Medical Center

    Published on 11/3/2014
  • Cerulean board of directors update

    Cerulean Pharma Inc. (NASDAQ:CERU), Cambridge, Mass. Business: Drug delivery, Cancer Appointed: Paul Friedman, a director, as executive chairman

    Published on 11/3/2014
  • Cerulean management update

    Cerulean Pharma Inc. (NASDAQ:CERU), Cambridge, Mass. Business: Drug delivery, Cancer Resigned: Oliver Fetzer as president, CEO and a director Transitioned: CBO Chris Guiffre to COO

    Published on 11/3/2014
  • Cydan Development Inc. management update

    Cydan Development Inc., Cambridge, Mass. Business: Pharmaceuticals Hired: Vered Bisker-Leib as CBO, formerly executive director and global head of business development for the cardiovascular and metabolic franchises at…

    Published on 11/3/2014
  • Epizyme management update

    Epizyme Inc. (NASDAQ:EPZM), Cambridge, Mass. Business: Cancer Departed: Eric Hedrick as CMO

    Published on 11/3/2014
  • Forma Therapeutics management update

    Forma Therapeutics Holdings LLC, Watertown, Mass. Business: Cancer, Computational chemistry/biology Hired: Helen Boudreau as CFO, formerly CFO of Novartis AG's Novartis Corp.

    Published on 11/3/2014
  • Impax management update

    Impax Laboratories Inc. (NASDAQ:IPXL), Hayward, Calif. Business: Drug delivery, Neurology, Generics Resigned: Carole Ben-Maimon as president of Impax's global pharmaceuticals generic division

    Published on 11/3/2014
  • InSilixa board of directors update

    InSilixa Inc., Sunnyvale, Calif. Business: Diagnostic Appointed: Gerald Chan, co-founder at Morningside Group; and Pete Thomas, managing director at PointGuard Ventures

    Published on 11/3/2014
  • Nabsys management update

    Nabsys Inc., Providence, R.I. Business: Genomics Hired: Anthony Shuber as VP and CSO, formerly VP and chief technology officer of Ignyta Inc.

    Published on 11/3/2014
  • Paion board of directors update

    Paion AG (Xetra:PA8), Aachen, Germany Business: Cardiovascular, Neurology Appointed: CEO Wolfgang Sohngen as chairman of Paion AG's Paion Inc. U.S. subsidiary

    Published on 11/3/2014
  • Paion management update

    Paion AG (Xetra:PA8), Aachen, Germany Business: Cardiovascular, Neurology Hired: Greg Papaz as CEO of Paion AG's Paion Inc. U.S. subsidiary, formerly SVP of commercial operations at Optimer Pharmaceuticals Inc., which …

    Published on 11/3/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993